Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Regulation and importance of factor VIII levels in hemophilia A carriers.

Current opinion in hematology - 1 Sept 2021

Cygan Peter H, Kouides Peter A

Abstract excerpt

PURPOSE OF REVIEW: To summarize the recent literature related to female hemophilia A carriers with respect to prevalence in the population, the impact of baseline factor VIII levels and other influences on bleeding phenotype, and clinical management needs. RECENT FINDINGS: Many female hemophilia A carriers are at risk for abnormal bleeding, yet they are underrecognized by healthcare providers and their bleeding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, X
Share to Factor VIII
Share to Hemophilia A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hemorrhage

Share to Heterozygote

Share to Phenotype

Source

Identifiers

PMID: 34397591
DOI: 10.1097/MOH.0000000000000667

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Regulation and importance of factor VIII levels in hemophilia A carriers.PMID 34397591Read ↗

A close insight to factor VIII inhibitor in the congenital hemophilia A.Semantic proximity Read ↗

X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.Semantic proximity Read ↗

Factor XIII Deficiency: Laboratory, Molecular, and Clinical AspectsSemantic proximity Read ↗

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and ChallengesSemantic proximity Read ↗

Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency.Semantic proximity Read ↗

The diagnosis and evaluation of women and girls with hemophilia and hemophilia carriers: guidance from the SSC of the ISTH.Semantic proximity Read ↗

Factor VII Deficiency: Clinical Phenotype, Genotype and TherapySemantic proximity Read ↗

Integrative modeling to improve bleeding risk prediction in adult female hemophilia A carriers.Semantic proximity Read ↗

Diagnosis and management of hemophilia A and B.Semantic proximity Read ↗

Factor XIII deficiency: an update.Semantic proximity Read ↗

Skewed Inactivation of X Chromosome: A Cause of Hemophilia Manifestation in Carrier FemalesSemantic proximity Read ↗

Acquired hemophilia A: Updated review of evidence and treatment guidance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.